US 11820775
Pyrrolopyrimidine ITK inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11820775 (Pyrrolopyrimidine ITK inhibitors) held by Aclaris Therapeutics, Inc. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aclaris Therapeutics, Inc.
- Grant date
- Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K45/06, A61P, A61P29/00, A61P37/00